Conditioning With Sevoflurane in Liver Transplantation: Results of a Multicenter Randomized Controlled Trial

Imagem de Miniatura
Arquivos
art_BECK-SCHIMMER_Conditioning_With_Sevoflurane_in_Liver_Transplantation_Results_of_2015.PDF (256.97 KB)
Citações na Scopus
37
Tipo de produção
article
Data de publicação
2015
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
BECK-SCHIMMER, Beatrice
BONVINI, John M.
SCHADDE, Erik
DUTKOWSKI, Philipp
OBERKOFLER, Christian E.
LESURTEL, Mickael
DEOLIVEIRA, Michelle L.
Citação
TRANSPLANTATION, v.99, n.8, p.1606-1612, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background. During times of organ scarcity and extended use of liver grafts, protective strategies in transplantation are gaining importance. We demonstrated in the past that volatile anesthetics such as sevoflurane attenuate ischemia-reperfusion injury during liver resection. In this randomized study, we examined if volatile anesthetics have an effect on acute graft injury and clinical outcomes after liver transplantation. Methods. Cadaveric liver transplant recipients were enrolled from January 2009 to September 2012 at 3 University Centers (Zurich/Sao Paulo/Ghent). Recipients were randomly assigned to propofol (control group) or sevoflurane anesthesia. Postoperative peak of aspartate transaminase was defined as primary endpoint, secondary endpoints were early allograft dysfunction, in-hospital complications, intensive care unit, and hospital stay. Results. Ninety-eight recipients were randomized to propofol (n = 48) or sevoflurane (n = 50). Median peak aspartate transaminase after transplantation was 925 (interquartile range, 512-3274) in the propofol and 1097 (interquartile range, 540-2633) in the sevoflurane group. In the propofol arm, 11 patients (23%) experienced early allograft dysfunction, 7 (14%) in the sevoflurane one (odds ratio, 0.64 (0.20 to 2.02, P = 0.45). There were 4 mortalities (8.3%) in the propofol and 2 (4.0%) in the sevoflurane group. Overall and major complication rates were not different. An effect on clinical outcomes was observed favoring the sevoflurane group (less severe complications), but without significance. Conclusions. This first multicenter trial comparing propofol with sevoflurane anesthesia in liver transplantation shows no difference in biochemical markers of acute organ injury and clinical outcomes between the 2 regimens. Sevoflurane has no significant added beneficial effect on ischemia-reperfusion injury compared to propofol.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/13367
Referências
  1. Stockmann M, 2010, TRANSPL INT, V23, P1023, DOI 10.1111/j.1432-2277.2010.01089.x
  2. Beck-Schimmer B, 2008, ANN SURG, V248, P909, DOI 10.1097/SLA.0b013e31818f3dda
  3. Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
  4. Kremers WK, 2004, HEPATOLOGY, V39, P764, DOI 10.1002/hep.20083
  5. Melloul E, 2012, SEMIN ONCOL, V39, P510, DOI 10.1053/j.seminoncol.2012.05.008
  6. Baskin-Bey ES, 2007, AM J TRANSPLANT, V7, P218, DOI 10.1111/j.1600-6143.2006.01595.x
  7. Lemke AJ, 2006, RADIOLOGY, V240, P736, DOI 10.1148/radiol.2403042062
  8. Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d
  9. Beck-Schimmer B, 2012, ANN SURG, V256, P837, DOI 10.1097/SLA.0b013e318272df7c
  10. De Bleser L, 2009, TRANSPL INT, V22, P780, DOI 10.1111/j.1432-2277.2009.00881.x
  11. Volk ML, 2011, LIVER TRANSPLANT, V17, P1443, DOI 10.1002/lt.22425
  12. Vinten-Johansen J, 2011, J CARDIOVASC PHARM T, V16, P260, DOI 10.1177/1074248411415270
  13. Guarrera JV, 2010, AM J TRANSPLANT, V10, P372, DOI 10.1111/j.1600-6143.2009.02932.x
  14. Dutkowski P, 2012, ANN SURG, V256, P861, DOI 10.1097/SLA.0b013e318272dea2
  15. Ko JS, 2008, LIVER TRANSPLANT, V14, P1150, DOI 10.1002/lt.21490
  16. Ko JS, 2010, TRANSPL INT, V23, P736, DOI 10.1111/j.1432-2277.2009.01050.x
  17. De Hert SG, 2008, MINERVA ANESTESIOL, V74, P259
  18. Landoni G, 2007, J CARDIOTHOR VASC AN, V21, P502, DOI 10.1053/j.jvca.2007.02.013
  19. Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
  20. Bahde R, 2010, BRIT J SURG, V97, P1461, DOI 10.1002/bjs.7176
  21. URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5
  22. Volk ML, 2011, ANN INTERN MED, V155, P503, DOI [10.7326/0003-4819-155-8-201110180-00006, 10.1059/0003-4819-155-8-201110180-00006]
  23. Axelrod DA, 2009, AM J TRANSPLANT, V9, P959, DOI 10.1111/j.1600-6143.2009.02570.x
  24. Azoulay D, 2006, J AM COLL SURGEONS, V202, P203, DOI 10.1016/j.jamcollsurg.2005.10.021
  25. Steadman Randolph H, 2004, Anesthesiol Clin North America, V22, P687, DOI 10.1016/j.atc.2004.06.009
  26. Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225
  27. McCormack L, 2007, ANN SURG, V246, P940, DOI 10.1097/SLA.0b013e31815c2a3f
  28. Song JC, 2010, ANESTH ANALG, V111, P1036, DOI 10.1213/ANE.0b013e3181effda8
  29. Balzan SMP, 2014, J SURG RES, V191, P134, DOI 10.1016/j.jss.2014.03.073
  30. Winbladh A, 2012, J HEPATO-BIL-PAN SCI, V19, P159, DOI 10.1007/s00534-011-0402-9
  31. Jaeck D, 2003, ANN SURG, V238, P851
  32. Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156
  33. Dutkowski P, 2012, ANN SURG, V256, P868, DOI 10.1097/SLA.0B013E318272DEA2
  34. Landoni G, 2009, HSR Proc Intensive Care Cardiovasc Anesth, V1, P34
  35. McCormack L, 2007, ANN SURG, V246, P946
  36. Minou AF, 2012, ANESTHESIOL RES PRAC, V2012
  37. Schulz KF, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c332

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/08
Artigos e Materiais de Revistas Científicas - LIM/37